Omega-3 Fatty Acids and Hypertriglyceridemia in HIV-Infected Subjects on Antiretroviral Therapy: Systematic Review and Meta-analysis

REFERENCES

• Barbaro G. Highly active antiretroviral therapy-associated metabolic syndrome: pathogenesis and cardiovascular risk. Am J Ther 2006;13:248–260.
   PubMed Web of Science ®Google Scholar
• Barbaro G, Barbarini G. Highly active antiretroviral ther-apy-associated metabolic syndrome and cardiovascular risk. Chemotherapy. 2006;52:161–165.
   PubMed Web of Science ®Google Scholar
• Oh J, Hegele RA. HIV-associated dyslipidaemia: patho-genesis and treatment. Lancet Infect Dis. 2007;7:787–796.
   PubMed Web of Science ®Google Scholar
• Früs-Moller N, Weber R, Reiss P, et al. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study. AIDS. 2003;17:1179–1193.
   PubMed Web of Science ®Google Scholar
• Thusgaard M, Christensen JH, Morn B, et al. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study. Scand J Infect Dis. 2009;41:760–766.
   PubMed Web of Science ®Google Scholar
• Baril JG, Kovacs CM, Trottier S, et al. Effectiveness and tolerability of oral administration of low-dose salmon oil to HIV patients with HAART-associated dyslipidemia. HIV Clin Trials. 2007;8:400–411.
   PubMed Web of Science ®Google Scholar
• De Truchis P, Kirstetter M, Perier A, et al. Reduction in triglyceride level with N-3 polyunsaturated fatty acids in HIV-infected patients taking potent antiretroviral therapy: a randomized prospective study. J Acquir Immune Defic Syndr 2007;44:278–285.
   PubMed Web of Science ®Google Scholar
• Wohl DA, Tien HC, Busby M, et al. Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counselling for the treatment of antiretroviral therapy-associated hypertri-glyceridemia. Clin Infect Dis. 2005;41:1498–1450.
   PubMed Web of Science ®Google Scholar
• Carter VM, Woolley I, Jolley D, Nyulasi I, Mijch A, Dart A. A randomised controlled trial of omega-3 fatty acid sup-plementation for the treatment of hypertriglyceridemia in HIV-infected males on highly active antiretroviral therapy. Sex Health. 2006;3:287–290.
   PubMedGoogle Scholar
• Manfredi R, Calza L, Chiodo F. Polyunsaturated ethyl esters of n-3 fatty acids in HIV-infected patients with mod-erate hypertriglyceridemia: comparison with dietary and lifestyle changes, and fibrate therapy. J Acquir Immune Defic Syndr 2004;36: 878–880.
   PubMed Web of Science ®Google Scholar
• McKenney JM, Sica D. Role of prescription omega-3 fatty acids in treatment of hypertriglyceridemia. Pharmaco-therapy. 2007;27:715–728.
   Web of Science ®Google Scholar
• Downs SH, Black N. The feasibility of creating a check-list for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998:52:377–384.
   PubMed Web of Science ®Google Scholar
• Harris WS. N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997;65:1645S–1654S.
   Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treat-ment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–3421.
   PubMed Web of Science ®Google Scholar
• Jacobson TA. Role of n-3 fatty acids in the treatment of hypertriglyceridaemia and cardiovascular disease. Am J Clin Nutr 2008;87:1981–1990
   PubMed Web of Science ®Google Scholar
• Kim SH, Kim MK, Lee HY, Kang HJ, Kim YJ, Kim HS. Prospective randomized comparison between omega-3 fatty acid supplements plus simvastatin versus simvastatin alone in Korean patients with mixed dyslipidemia: lipo-protein profiles and heart rate variability. Eur J Clin Nutr. 2011;65:110–116.
   PubMed Web of Science ®Google Scholar
• Davidson MH, Stein EA, Bays HE, et al; COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators. Efficacy and tolerability of adding prescrip-tion omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, random-ized, double-blind, placebo-controlled study. Clin Ther. 2007;29:1354–1367.
   PubMed Web of Science ®Google Scholar
• Gerber JG, Kitch DW, Fichtenbaum CJ, et al. Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186. J Acquir Immune Defic Syndr 2008;47:459–466.
   PubMed Web of Science ®Google Scholar
• Eslick GD. Benefits of fish oil supplementation in hyper-lipidemia: a systematic review and meta-analysis. Int J CardioL 2009;136:4–16.
   PubMed Web of Science ®Google Scholar
• Musa-Veloso K, Binns MA, Kocenas AC, et al. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosa-hexaenoic acid dose-dependently reduce fasting serum triglycerides. Nutr Rev. 2010;68:155–167.
   PubMed Web of Science ®Google Scholar
• Sadovsky R, Kris-Etherton P. Prescription omega-3-acid ethyl esters for the treatment of very high triglycerides. Postgrad Med. 2009;121:145–153.
   PubMed Web of Science ®Google Scholar
• Raatz SK, Redmon JB, Wimmergren N, Donadio JV, Bibus DM. Enhanced absorption of n-3 fatty acids from emulsi-fied compared with encapsulated fish oil. J Am Diet Assoc. 2009;109:1076–1081.
   PubMed Web of Science ®Google Scholar
• Ryan AS, Keske MA, Hoffman JP, Nelson EB. Clinical over-view of algal-docosahexaenoic acid: effects on triglyceride levels and other cardiovascular risk factors. Am J Ther. 2009;16:183–192.
   PubMed Web of Science ®Google Scholar
• Kris-Etherton PM, William SH, Appel U. Fish consump-tion, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747–2757.
   PubMed Web of Science ®Google Scholar
• Madsen T, Christensen JH, Schmidt EB. C-reactive protein and n-3 fatty acids in patients with a previous myocardial infarction: a placebo-controlled randomized study. Eur J Nutr 2007;46:428–430.
   PubMed Web of Science ®Google Scholar
• Kennel WB, Vasan RS. Triglycerides as vascular risk factors: new epidemiologic insights. Curr Opin CardioL 2009;24:345–350.
   PubMed Web of Science ®Google Scholar
• European AIDS Clinical Society (EACS). Prevention and management of non-infectious co-morbidities in HIV. Ver-sion 4–5.2009. www.europeanaidsclinicalsociety.org
   Google Scholar